Vital Therapies

Vital Therapies is a biotherapeutic company developing a cell-based system for the treatment of acute forms of liver failure. The Company’s lead product candidate, the ELAD® System, is a human cell-based, bio-artificial liver support system currently in Phase III clinical trials. 

ELAD is an investigational extracorporeal liver support system designed with the proposed intent to supplement hepatic function in order to improve survival rates among subjects with liver failure. Data from ELAD system clinical studies have shown trends that may indicate a potential for ELAD to increase survival rates in patients with liver failure.

Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
2003
Size (employees)
87 (est)
Vital Therapies was founded in 2003 and is headquartered in San Diego, US

Vital Therapies Office Locations

Vital Therapies has an office in San Diego
San Diego, US (HQ)
15010 Avenue of Science

Vital Therapies Financials and Metrics

Vital Therapies Financials

USD

Net income (Q1, 2017)

(12.6 m)

EBIT (Q1, 2017)

(12.7 m)

Market capitalization (19-Oct-2017)

236.4 m

Cash (31-Mar-2017)

86.6 m
Vital Therapies's current market capitalization is $236.4 m.
USDFY, 2014FY, 2015FY, 2016

R&D expense

39.5 m39.8 m30 m

General and administrative expense

10.9 m12.3 m11.2 m

Operating expense total

50.3 m52.1 m41.3 m

EBIT

(50.3 m)(52.1 m)(41.3 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

R&D expense

9.1 m10.2 m11.8 m11.5 m9.6 m6.9 m6.9 m7.5 m9.6 m

General and administrative expense

2.5 m2.6 m3.1 m3.5 m2.7 m2.8 m2.7 m2.8 m3.1 m

Operating expense total

11.6 m12.8 m14.8 m15.1 m12.3 m9.7 m9.5 m10.2 m12.7 m

EBIT

(11.6 m)(12.8 m)(14.8 m)(15.1 m)(12.3 m)(9.7 m)(9.5 m)(10.2 m)(12.7 m)
USDFY, 2014FY, 2015FY, 2016

Cash

102.2 m83.4 m60 m

Inventories

1.3 m30.2 m20.8 m

Current Assets

104.8 m85.1 m61.5 m

PP&E

3.1 m3.8 m2.5 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

90.8 m79.1 m88.3 m71.9 m59.8 m77.9 m73.6 m68.1 m86.6 m

Current Assets

93.5 m82.6 m90.6 m75.4 m62.6 m79.2 m75.4 m69.5 m88.3 m

PP&E

3.3 m3 m4.1 m4.2 m4.2 m3.4 m3 m2.9 m2.5 m

Total Assets

97 m85.8 m94.9 m79.9 m66.9 m82.9 m78.6 m72.5 m90.9 m
USDFY, 2014FY, 2015FY, 2016

Net Income

(47.7 m)(52 m)(41 m)

Depreciation and Amortization

1.1 m1.3 m1.8 m

Inventories

(6.5 m)

Accounts Payable

46 k281 k(459 k)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(10.2 m)(12.8 m)(14.8 m)(15.1 m)(12.3 m)(9.6 m)(9.5 m)(10.2 m)(12.6 m)

Accounts Payable

1.5 m696 k1.1 m920 k549 k885 k887 k1.2 m1.3 m
Y, 2017

Financial Leverage

1.1 x
Show all financial metrics

Vital Therapies Market Value History

Traffic Overview of Vital Therapies

Vital Therapies Company Life and Culture

You may also be interested in